[144] VeriSign Inc SEC Filing

Rhea-AI Filing Summary

VeriSign Inc. Form 144 notifies a proposed sale of 501 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $132,514.50, an approximate sale date of 08/12/2025 and listing on NASDAQ. The filing reports total shares outstanding of 93,400,000.

The 501 shares to be sold were acquired as 134 performance shares on 02/13/2025 and 367 restricted stock on 02/15/2025. The filing also lists multiple sales by Thomas C. Indelicarto in the past three months, including sales of 501 shares on 08/05/2025, 07/08/2025, 07/01/2025, 06/10/2025, 06/03/2025 and 05/20/2025, and two partial sales on 05/27/2025 (258 and 243 shares), with gross proceeds reported for each sale in the filing.

Insights

Financial Analyst

TL;DR: Proposed sale is immaterial relative to outstanding shares; repeated small filings indicate routine sales, limited near-term market impact.

The filing shows a proposed disposition of 501 shares against 93,400,000 shares outstanding, representing roughly 0.0005% of the float, which is immaterial from a market-cap perspective. The shares were recently acquired via compensation (performance shares and restricted stock) in February 2025. Multiple sales by the named seller are disclosed in the past three months, but sizes and frequency are small relative to total outstanding shares, suggesting low likelihood of material investor impact based on the notice alone.

Corporate Governance Expert

TL;DR: Repeated Form 144 disclosures document ongoing sales by the named individual; documentation is standard and does not itself imply undisclosed company information.

The filing identifies the broker as Morgan Stanley Smith Barney LLC and documents that the 501 shares offered were acquired as performance awards (02/13/2025) and restricted stock (02/15/2025). The record of several transactions by Thomas C. Indelicarto in recent months is clearly disclosed. From a governance and disclosure standpoint, the form provides required transparency but contains no statements of material adverse information or indications of policy breaches.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	501	132514.50	93400000	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2025	Performance Shares	ISSUER			134	02/13/2025	Not Applicable
Common	02/15/2025	Restricted Stock	ISSUER			367	02/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	08/05/2025	501	135019.50
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	07/08/2025	501	143837.10
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	07/01/2025	501	145372.67
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	06/10/2025	501	140540.52
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	06/03/2025	501	137995.44
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	05/27/2025	258	72756.00
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	05/27/2025	243	68526.00
THOMAS C INDELICARTO 12061 Bluemont Way Reston VA 20190	Common	05/20/2025	501	141171.78

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VeriSign (VRSN) Form 144 report?

The filing reports a proposed sale of 501 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $132,514.50 and approximate sale date 08/12/2025 on NASDAQ.

Who is named as a recent seller in the filing for VRSN?

The filing lists Thomas C. Indelicarto as the seller in multiple transactions reported in the past three months.

How were the 501 shares to be sold acquired?

The 501 shares were acquired as 134 performance shares on 02/13/2025 and 367 restricted stock on 02/15/2025.

How many VeriSign shares are outstanding according to the filing?

The filing reports 93,400,000 shares outstanding.

What recent sales in the past three months are disclosed?

The filing lists several sales by Thomas C. Indelicarto, including sales of 501 shares on 08/05/2025, 07/08/2025, 07/01/2025, 06/10/2025, 06/03/2025 and 05/20/2025, plus two partial sales on 05/27/2025 (258 and 243 shares); gross proceeds for each sale are provided in the filing.

Which broker is handling the proposed sale in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC.